Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction

Creative Commons License

Mascherbauer J., Marzluf B. A., Tufaro C., Pfaffenberger S., Graf A., Wexberg P., ...Daha Fazla

CIRCULATION-CARDIOVASCULAR IMAGING, cilt.6, sa.6, ss.1056-1065, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 6 Sayı: 6
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1161/circimaging.113.000633
  • Dergi Adı: CIRCULATION-CARDIOVASCULAR IMAGING
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1056-1065
  • Anahtar Kelimeler: hypertension, pulmonary, magnetic resonance imaging, prognosis, DIFFUSE MYOCARDIAL FIBROSIS, EUROPEAN-SOCIETY, HYPERTROPHIC CARDIOMYOPATHY, PULMONARY-HYPERTENSION, SYSTOLIC FUNCTION, RISK-FACTORS, TASK-FORCE, ECHOCARDIOGRAPHY, DYSFUNCTION, COLLAGEN
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Background The underlying pathophysiology of heart failure with preserved ejection fraction (HFPEF) is incompletely understood, but myocardial extracellular matrix accumulation is thought to play a major role. Our aims were to estimate myocardial extracellular matrix using cardiac magnetic resonance T1 mapping and to assess the relationship between pathobiology/pathophysiology and prognosis.